Additional information
| Dosage Form | Tablets |
|---|---|
| Specialities | Neurologist, Physician |
| Therapeutic Segment | Antidepressants |
Agomelatine is an agonist at both melatonin MT1 receptors (attenuating alerting signals to the cortex) and MT2 receptors (producing a phase-shifting action on the circadian rhythm of sleep). Agomelatine significantly improves sleep quality when taken at night to mimic the natural rhythm of melatonin release.
As directed by physician
